UK small-cap RNS · 29 May 2026
Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.
Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.
| Time | Company | Mcap ↕ | Type | Announcement | |
|---|---|---|---|---|---|
| 14:03 | Maintel Holdings MAI | £11m | Balance-sheet stress / refinancing | Result of Retail Offer and Update on Timing
Maintel is pleased to announce that, further to its announcement of 13 May 2026 the Retail Offer that launched on that date has now closed, raising gross proceeds of approximately £0.5 million. |
|
| 12:46 | Petra Diamonds Ltd. PDL | £9.2m | Balance-sheet stress / refinancing | Business Update
Vivek Gadodia, Chief Executive Officer of Petra Diamonds, commented: |
|
| 11:56 | Everyman Media Group EMAN | £47m | Insider conviction | Director/PDMR Shareholding | |
| 09:03 | Georgina Energy plc GEX | £27m | Project milestones | Audited Final Results for Year Ended 31 Jan 2026
Georgina Energy plc is pleased to announce the publication of its audited results for the year ended 31 January 2026 ("FY 2026"). |
|
| 07:00 | Pulsar Helium Inc PLSR | £144m | Project milestones | Acquires Strategic Surface Land at Topaz Project
The surface land was purchased in an arm's length transaction from Wolf Lands Inc. for total cash consideration of US$2,480,000 to be satisfied through the Company's existing cash resources. |
|
| 07:00 | Clean Power Hydrogen CPH2 | £12m | Project milestones | 1MW MFE220 Factory Acceptance Test update
596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. |
|
| 07:00 | B.P. Marsh & Partners BPM | £245m | Insider conviction | Director/PDMR Shareholding | |
| 07:00 | Great Western Mining Corporation (CDI) GWMO | £13m | Project milestones | Final Results
Great Western Mining Corporation PLC / AIM: GWMO / Euronext Growth: 8GW |
|
| 07:00 | CelLBxHealth plc CLBX | £6.8m | Turnaround plan with targets | MSA with Global Pharmaceutical Company
Guildford, UK and Plymouth Meeting, U.S. - 29 May 2026 - CelLBxHealth plc (AIM: CLBX), a CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, announces that it … |
|
| 07:00 | Blencowe Resources BRES | £31m | Project milestones | Orom Cross Graphite DFS NPV10 up 15% to US$1.254bn
NPV10 rises 15% to US$1.254bn; Capex Unchanged; New Offtakes and Downstream Pathways Incorporated |